A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score

Introduction: Platinum-based chemotherapy is the first-line treatment strategy for ovarian cancer patients. The dismal prognosis of ovarian cancer was shown to be stringently associated with the heterogeneity of tumor cells in response to this therapy, therefore understanding platinum sensitivity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Wei, Wei, Li, Ganghua, Lan, Qiongyu, Liu, Xiwei, Gao, Lin, Zhang, Chao, Fan, Jiangtao, Li, Jundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508345/
https://www.ncbi.nlm.nih.gov/pubmed/37732324
http://dx.doi.org/10.3389/fgene.2023.1240068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508345/
https://www.ncbi.nlm.nih.gov/pubmed/37732324
http://dx.doi.org/10.3389/fgene.2023.1240068

Ejemplares similares